Perrigo Company plc Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax
Perrigo Company plc (PRGO) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax of $1.40 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax · last filed 2026-08-05
- Perrigo Company plc other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for the quarter ending 2026-06-27 was $1.40M.
- Perrigo Company plc other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for the quarter ending 2026-03-28 was $8.80M.
- Perrigo Company plc other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for the quarter ending 2025-12-31 was -$1.60M, a 105.18% decline year-over-year.
- Perrigo Company plc other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for the quarter ending 2025-09-27 was $500.00K.
- Perrigo Company plc other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for fiscal 2025 was -$13.90M, a 133.10% decline from fiscal 2024.
- Perrigo Company plc other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for fiscal 2024 was $42.00M.
- Perrigo Company plc other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for fiscal 2023 was -$32.20M, a 158.97% decline from fiscal 2022.
- Perrigo Company plc other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for fiscal 2022 was $54.60M, a 857.89% increase from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 3 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 6 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 9 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 12 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-27 | $1.40M 10-Q · filed 2026-08-05 | $10.30M 10-Q · filed 2026-08-05 | $8.60M derived: sum of 3 quarters · filed 2026-08-05 | $9.10M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-28 | $8.80M 10-Q · filed 2026-05-06 | $7.20M derived: sum of 2 quarters · filed 2026-05-06 | $7.70M derived: sum of 3 quarters · filed 2026-05-06 | $5.50M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.10M derived: sum of 2 quarters · filed 2026-02-26 | -$3.30M derived: sum of 3 quarters · filed 2026-08-05 | -$13.90M 10-K · filed 2026-02-26 | ||||
| 2025-09-27 | $500.00K 10-Q · filed 2025-11-05 | -$1.70M derived: sum of 2 quarters · filed 2026-08-05 | -$12.30M 10-Q · filed 2025-11-05 | $18.60M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-28 | -$2.20M 10-Q · filed 2026-08-05 | -$12.80M 10-Q · filed 2026-08-05 | $18.10M derived: sum of 3 quarters · filed 2026-08-05 | -$10.40M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-29 | -$10.60M 10-Q · filed 2026-05-06 | $20.30M derived: sum of 2 quarters · filed 2026-05-06 | -$8.20M derived: sum of 3 quarters · filed 2026-05-06 | -$2.10M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $30.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.40M derived: sum of 2 quarters · filed 2026-02-26 | $8.50M derived: sum of 3 quarters · filed 2026-02-26 | $42.00M 10-K · filed 2026-02-26 | ||||
| 2024-09-28 | -$28.50M 10-Q · filed 2025-11-05 | -$22.40M derived: sum of 2 quarters · filed 2025-11-05 | $11.10M 10-Q · filed 2025-11-05 | -$24.10M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-29 | $6.10M 10-Q · filed 2025-08-06 | $39.70M 10-Q · filed 2025-08-06 | $4.40M derived: sum of 3 quarters · filed 2026-02-26 | $15.30M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-30 | $34.40M 10-Q · filed 2025-05-07 | -$1.70M derived: sum of 2 quarters · filed 2026-02-26 | $9.20M derived: sum of 3 quarters · filed 2026-02-26 | $32.30M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$36.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$25.20M derived: sum of 2 quarters · filed 2026-02-26 | -$2.10M derived: sum of 3 quarters · filed 2026-02-26 | -$32.20M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $10.90M 10-Q · filed 2024-11-06 | $34.00M derived: sum of 2 quarters · filed 2024-11-06 | $3.90M 10-Q · filed 2024-11-06 | $50.90M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-07-01 | $23.10M 10-Q · filed 2024-08-02 | -$7.00M 10-Q · filed 2024-08-02 | $40.00M derived: sum of 3 quarters · filed 2025-02-28 | $107.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-04-01 | $18.20M 10-Q · filed 2024-05-07 | $16.90M derived: sum of 2 quarters · filed 2025-02-28 | $83.90M derived: sum of 3 quarters · filed 2025-02-28 | $80.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $65.70M derived: sum of 2 quarters · filed 2025-02-28 | $61.80M derived: sum of 3 quarters · filed 2025-02-28 | $54.60M 10-K · filed 2025-02-28 | ||||
| 2022-10-01 | $67.00M 10-Q · filed 2023-11-07 | $63.10M derived: sum of 2 quarters · filed 2023-11-07 | $55.90M 10-Q · filed 2023-11-07 | $59.60M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-07-02 | -$3.90M 10-Q · filed 2023-08-08 | -$11.10M 10-Q · filed 2023-08-08 | -$7.40M derived: sum of 3 quarters · filed 2024-02-27 | -$5.00M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-04-02 | -$7.20M 10-Q · filed 2023-05-09 | -$3.50M derived: sum of 2 quarters · filed 2024-02-27 | -$1.10M derived: sum of 3 quarters · filed 2024-02-27 | $0.00 derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $6.10M derived: sum of 2 quarters · filed 2024-02-27 | $7.20M derived: sum of 3 quarters · filed 2024-02-27 | $5.70M 10-K · filed 2024-02-27 | ||||
| 2021-10-02 | $2.40M 10-Q · filed 2022-11-08 | $3.50M derived: sum of 2 quarters · filed 2022-11-08 | $2.00M 10-Q · filed 2022-11-08 | $1.90M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-07-03 | $1.10M 10-Q · filed 2022-08-09 | -$1.20M 10-Q · filed 2022-08-09 | -$500.00K derived: sum of 3 quarters · filed 2023-02-28 | -$2.00M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-04-03 | $1.70M 10-Q · filed 2022-05-11 | -$1.60M derived: sum of 2 quarters · filed 2023-02-28 | -$3.10M derived: sum of 3 quarters · filed 2023-02-28 | -$2.60M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | -$3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$4.80M derived: sum of 2 quarters · filed 2023-02-28 | -$4.30M derived: sum of 3 quarters · filed 2023-02-28 | $5.00M 10-K · filed 2023-02-28 | $7.30M 10-K · filed 2021-03-01 | |||
| 2020-09-26 | -$1.50M 10-Q · filed 2021-11-12 | -$2.60M 10-Q · filed 2020-11-05 | -$1.00M derived: sum of 2 quarters · filed 2021-11-12 | $8.30M 10-Q · filed 2021-11-12 | $7.40M 10-Q · filed 2020-11-05 | $3.30M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-27 | $500.00K 10-Q · filed 2021-08-11 | $3.00M 10-Q · filed 2020-08-05 | $9.80M 10-Q · filed 2021-08-11 | $9.90M 10-Q · filed 2020-08-05 | $4.80M derived: sum of 3 quarters · filed 2022-03-01 | $7.40M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-28 | $9.30M 10-Q · filed 2021-05-12 | $7.00M 10-Q · filed 2020-05-05 | $4.30M derived: sum of 2 quarters · filed 2022-03-01 | $6.90M derived: sum of 3 quarters · filed 2022-03-01 | $8.00M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -$5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$2.40M derived: sum of 2 quarters · filed 2022-03-01 | -$1.30M derived: sum of 3 quarters · filed 2022-03-01 | -$2.40M 10-K · filed 2022-03-01 | -$1.20M 10-K · filed 2020-02-27 | |||
| 2019-09-28 | $2.60M 10-Q · filed 2020-11-05 | $3.70M derived: sum of 2 quarters · filed 2020-11-05 | $2.60M 10-Q · filed 2020-11-05 | |||||
| 2019-06-29 | $1.10M 10-Q · filed 2020-08-05 | $0.00 10-Q · filed 2020-08-05 | ||||||
| 2019-03-30 | -$1.00M 10-Q · filed 2020-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |